Published in BMC Neurosci on July 08, 2009
The Anti-Amyloid-β and Neuroprotective Properties of a Novel Tricyclic Pyrone Molecule. J Alzheimers Dis (2017) 0.75
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell (1996) 12.59
Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res (1993) 9.81
Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell (1997) 9.57
Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol (1985) 7.93
Endocytosis. Physiol Rev (1997) 7.33
Disruption of axonal transport by loss of huntingtin or expression of pathogenic polyQ proteins in Drosophila. Neuron (2003) 4.04
A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron (1999) 3.50
Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem Sci (1999) 3.48
Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell (1995) 3.45
The hunt for huntingtin function: interaction partners tell many different stories. Trends Biochem Sci (2003) 3.15
Alzheimer's disease: the cholesterol connection. Nat Neurosci (2003) 2.99
Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature (1995) 2.92
Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet (2004) 2.88
A huntingtin-associated protein enriched in brain with implications for pathology. Nature (1995) 2.67
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol (2004) 2.65
Neuropathogenic forms of huntingtin and androgen receptor inhibit fast axonal transport. Neuron (2003) 2.50
Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nat Genet (1998) 2.42
Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol Biol Cell (2003) 2.05
Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid beta-peptide. Nat Cell Biol (2001) 1.96
CAG repeat disorder models and human neuropathology: similarities and differences. Acta Neuropathol (2007) 1.86
The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer's disease. Neuron (2004) 1.71
Roles of acyl-coenzyme A:cholesterol acyltransferase-1 and -2. Curr Opin Lipidol (2001) 1.70
Small molecule protein-protein interaction inhibitors as CNS therapeutic agents: current progress and future hurdles. Neuropsychopharmacology (2008) 1.68
Cholesterol and the biology of Alzheimer's disease. Neuron (2004) 1.64
Rings of membrane sterols surround the openings of vesicles and fenestrae, in capillary endothelium. J Cell Biol (1983) 1.40
Pathophysiology of Huntington's disease: from huntingtin functions to potential treatments. Curr Opin Neurol (2008) 1.40
Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation. BMC Neurosci (2005) 1.35
Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease. J Cell Sci (2002) 1.34
ACAT2 deficiency limits cholesterol absorption in the cholesterol-fed mouse: impact on hepatic cholesterol homeostasis. Hepatology (2004) 1.29
Wild-type huntingtin plays a role in brain development and neuronal survival. Mol Neurobiol (2003) 1.24
Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. Hum Mol Genet (2006) 1.19
A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes. J Neurochem (2006) 1.18
Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease. Prog Neurobiol (2007) 1.12
Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc Natl Acad Sci U S A (2003) 1.11
Pyripyropenes, highly potent inhibitors of acyl-CoA:cholesterol acyltransferase produced by Aspergillus fumigatus. J Antibiot (Tokyo) (1993) 1.07
Clathrin-independent internalization and recycling. J Cell Mol Med (2007) 1.06
Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo. J Neurochem (2009) 1.05
Cytotoxicity mediated by conditional expression of a carboxyl-terminal derivative of the beta-amyloid precursor protein. Brain Res Mol Brain Res (1994) 1.03
Regulation of intracellular HAP1 trafficking. J Neurosci Res (2007) 0.99
Novel therapeutic modalities to address nondrugable protein interaction targets. Neuropsychopharmacology (2008) 0.97
Huntington's disease gene product, huntingtin, associates with microtubules in vitro. Brain Res Mol Brain Res (1997) 0.96
Unraveling the mysteries of protein folding and misfolding. IUBMB Life (2008) 0.95
Mouse Huntington's disease gene homolog (Hdh). Somat Cell Mol Genet (1994) 0.93
Novel tricyclic pyrone compounds prevent intracellular APP C99-induced cell death. J Mol Neurosci (2002) 0.88
Glutamine repeats as polar zippers: their role in inherited neurodegenerative disease. Mol Med (1995) 0.85
Regulation of endosome dynamics by Rab5 and Huntingtin-HAP40 effector complex in physiological versus pathological conditions. Methods Enzymol (2008) 0.84
Syntheses of tricyclic pyrones and pyridinones and protection of Abeta-peptide induced MC65 neuronal cell death. Bioorg Med Chem Lett (2008) 0.82
Neuronal intranuclear inclusions in polyglutamine diseases: nuclear weapons or nuclear fallout? Neuron (1998) 0.81
An inhibitor of acylCoA: cholesterol acyltransferase increases expression of ATP-binding cassette transporter A1 and thereby enhances the ApoA-I-mediated release of cholesterol from macrophages. Biochim Biophys Acta (2004) 0.78
The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair. Nature (2002) 3.48
OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature (2007) 3.03
(CAG)(n)-hairpin DNA binds to Msh2-Msh3 and changes properties of mismatch recognition. Nat Struct Mol Biol (2005) 2.71
Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol (2004) 2.65
Bacteriophage phi29 scaffolding protein gp7 before and after prohead assembly. Nat Struct Biol (2003) 1.74
Features of trinucleotide repeat instability in vivo. Cell Res (2008) 1.70
Coordination between polymerase beta and FEN1 can modulate CAG repeat expansion. J Biol Chem (2009) 1.37
Genetics and etiopathophysiology of schizophrenia. Mayo Clin Proc (2002) 1.37
Comprehensive macromolecular conformations mapped by quantitative SAXS analyses. Nat Methods (2013) 1.29
The nucleotide binding dynamics of human MSH2-MSH3 are lesion dependent. Nat Struct Mol Biol (2009) 1.25
Synthesis and anti-norovirus activity of pyranobenzopyrone compounds. Bioorg Med Chem Lett (2012) 1.22
Conformational trapping of mismatch recognition complex MSH2/MSH3 on repair-resistant DNA loops. Proc Natl Acad Sci U S A (2011) 1.21
Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo. Hum Mol Genet (2006) 1.19
A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid-beta oligomeric complexes. J Neurochem (2006) 1.18
Nuclease-deficient FEN-1 blocks Rad51/BRCA1-mediated repair and causes trinucleotide repeat instability. Mol Cell Biol (2003) 1.17
Synthesis and anti-breast cancer activities of substituted quinolines. Bioorg Med Chem Lett (2008) 1.17
Biodegradable nanogels for oral delivery of interferon for norovirus infection. Antiviral Res (2010) 1.14
Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington's disease. Cell Rep (2012) 1.12
Cancer, cadmium and genome integrity. Nat Genet (2003) 1.11
Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc Natl Acad Sci U S A (2003) 1.11
Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Abeta oligomer-induced cytotoxicity. Brain Res (2006) 1.07
Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo. J Neurochem (2009) 1.05
Neurological abnormalities in caveolin-1 knock out mice. Behav Brain Res (2006) 1.04
Environmental and occupational risk factors for amyotrophic lateral sclerosis: a case-control study. Neurodegener Dis (2013) 1.03
Single-stranded DNA-binding protein in vitro eliminates the orientation-dependent impediment to polymerase passage on CAG/CTG repeats. J Biol Chem (2008) 1.00
Cockayne syndrome B protein antagonizes OGG1 in modulating CAG repeat length in vivo. Aging (Albany NY) (2011) 1.00
DNA packaging motor assembly intermediate of bacteriophage phi29. J Mol Biol (2008) 1.00
Crosstalk of DNA glycosylases with pathways other than base excision repair. DNA Repair (Amst) (2006) 0.99
Inhibition of norovirus 3CL protease by bisulfite adducts of transition state inhibitors. Bioorg Med Chem Lett (2012) 0.98
Synthesis and antiviral activity of substituted quercetins. Bioorg Med Chem Lett (2011) 0.94
Retinoic acid-induced differentiation increases the rate of oxygen consumption and enhances the spare respiratory capacity of mitochondria in SH-SY5Y cells. Mech Ageing Dev (2012) 0.93
Selective and irreversible inhibitors of mosquito acetylcholinesterases for controlling malaria and other mosquito-borne diseases. PLoS One (2009) 0.91
Resolving brain regions using nanostructure initiator mass spectrometry imaging of phospholipids. Integr Biol (Camb) (2012) 0.91
CTLA4 is associated with susceptibility to multiple sclerosis. J Neuroimmunol (2003) 0.90
Candidate anti-A beta fluorene compounds selected from analogs of amyloid imaging agents. Neurobiol Aging (2008) 0.90
CAG repeat lengths in X- and Y-bearing sperm indicate that gender bias during transmission of Huntington's disease gene is determined in the embryo. J Biol Chem (2003) 0.89
Second-generation substituted quinolines as anticancer drugs for breast cancer. Anticancer Res (2010) 0.88
A brief history of triplet repeat diseases. Methods Mol Biol (2013) 0.88
Novel tricyclic pyrone compounds prevent intracellular APP C99-induced cell death. J Mol Neurosci (2002) 0.88
Kinetic properties of alternatively spliced isoforms of laccase-2 from Tribolium castaneum and Anopheles gambiae. Insect Biochem Mol Biol (2011) 0.87
ATP hydrolysis by RAD50 protein switches MRE11 enzyme from endonuclease to exonuclease. J Biol Chem (2011) 0.87
Novel triacsin C analogs as potential antivirals against rotavirus infections. Eur J Med Chem (2012) 0.86
Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors. Bioorg Med Chem Lett (2013) 0.86
Dynamics of hydrogen-deuterium exchange in Chlamydomonas centrin. Biochemistry (2005) 0.86
A population-based study of IL4 polymorphisms in multiple sclerosis. J Neuroimmunol (2003) 0.86
Structure and function of eritadenine and its 3-deaza analogues: potent inhibitors of S-adenosylhomocysteine hydrolase and hypocholesterolemic agents. Biochem Pharmacol (2006) 0.85
Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling. Biochem Pharmacol (2004) 0.85
Culture of adult mouse neurons. Biotechniques (2005) 0.85
The effect of the PQ1 anti-breast cancer agent on normal tissues. Anticancer Drugs (2012) 0.85
Electrochemical Protease Biosensor Based on Enhanced AC Voltammetry Using Carbon Nanofiber Nanoelectrode Arrays. J Phys Chem C Nanomater Interfaces (2013) 0.84
Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. J Bone Miner Res (2003) 0.84
Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus. Bioorg Med Chem Lett (2013) 0.84
Triplet repeats and DNA repair: germ cell and somatic cell instability in transgenic mice. Methods Mol Biol (2004) 0.83
Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells. Anticancer Drugs (2010) 0.83
Protection of retinal cells from ischemia by a novel gap junction inhibitor. Biochem Biophys Res Commun (2008) 0.83
Antitumor triptycene bisquinones: a novel synthetic class of dual inhibitors of DNA topoisomerase I and II activities. Anticancer Drugs (2003) 0.82
Novel selective and irreversible mosquito acetylcholinesterase inhibitors for controlling malaria and other mosquito-borne diseases. Sci Rep (2013) 0.82
Loss of caveolin-1 expression in knock-in mouse model of Huntington's disease suppresses pathophysiology in vivo. Hum Mol Genet (2013) 0.82
Bidirectional transcription of trinucleotide repeats: roles for excision repair. DNA Repair (Amst) (2013) 0.82
Syntheses of tricyclic pyrones and pyridinones and protection of Abeta-peptide induced MC65 neuronal cell death. Bioorg Med Chem Lett (2008) 0.82
Rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria treated with anti-tumor 1,4-anthracenediones. Anticancer Drugs (2005) 0.81
Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling. Anticancer Drugs (2004) 0.81
Distinct pools of non-glycolytic substrates differentiate brain regions and prime region-specific responses of mitochondria. PLoS One (2013) 0.81
Anti-breast cancer agents, quinolines, targeting gap junction. Med Chem (2011) 0.80
Explorations of substituted urea functionality for the discovery of new activators of the heme-regulated inhibitor kinase. J Med Chem (2013) 0.80
Sculpting of DNA at abasic sites by DNA glycosylase homolog mag2. Structure (2012) 0.80
Bioactivity and molecular targets of novel substituted quinolines in murine and human tumor cell lines in vitro. Int J Oncol (2010) 0.80
Label-free electrochemical impedance detection of kinase and phosphatase activities using carbon nanofiber nanoelectrode arrays. Anal Chim Acta (2012) 0.80
Myeloperoxidase -463 (G-->A) polymorphism associated with lower risk of lung cancer. Mayo Clin Proc (2002) 0.80
Antitumor triptycene analogs directly interact with isolated mitochondria to rapidly trigger markers of permeability transition. Anticancer Res (2007) 0.79
Bioavailability and efficacy of a gap junction enhancer (PQ7) in a mouse mammary tumor model. PLoS One (2013) 0.79
Synthesis, molecular targets, and antitumor activities of substituted tetrahydro-1-oxopyrano[4,3-b][1]benzopyrans and nanogels for drug delivery. Anticancer Agents Med Chem (2009) 0.79
Redox potentials, laccase oxidation, and antilarval activities of substituted phenols. Bioorg Med Chem (2012) 0.78
Transport by OATP1B1 and OATP1B3 enhances the cytotoxicity of epigallocatechin 3-O-gallate and several quercetin derivatives. J Nat Prod (2013) 0.78
CD95 polymorphisms are associated with susceptibility to MS in women. A population-based study of CD95 and CD95L in MS. J Neuroimmunol (2004) 0.78
Combination of nanogel polyethylene glycol-polyethylenimine and 6(hydroxymethyl)-1,4-anthracenedione as an anticancer nanomedicine. J Nanosci Nanotechnol (2008) 0.78
Induction of poly(ADP-ribose) polymerase-1 cleavage by antitumor triptycene bisquinones in wild-type and daunorubicin-resistant HL-60 cell lines. Cancer Lett (2002) 0.78
Novel substituted 1,4-anthracenediones with antitumor activity directly induce permeability transition in isolated mitochondria. Int J Oncol (2007) 0.77
Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship Study. J Med Chem (2016) 0.76
In silico modeling of ligand molecule for non structural 3 (NS3) protein target of flaviviruses. Bioinformation (2012) 0.76
Antitumor triptycene analogs induce a rapid collapse of mitochondrial transmembrane potential in HL-60 cells and isolated mitochondria. Int J Oncol (2006) 0.75
Irreversible binding of an anticancer compound (BI-94) to plasma proteins. Xenobiotica (2015) 0.75
Correction: Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor. PLoS Pathog (2016) 0.75
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC). Chem Commun (Camb) (2017) 0.75
Unexpected differences in the alpha-halogenation and related reactivity of sulfones with perhaloalkanes in KOH-t-BuOH. J Org Chem (2003) 0.75
Reversible CT perfusion abnormalities in patient with migraine variant: a two phase process. Clin Neurol Neurosurg (2012) 0.75
Towards understanding region-specificity of triplet repeat diseases: coupled immunohistology and mass spectrometry imaging. Methods Mol Biol (2013) 0.75
Synthesis of cyclododeciptycene quinones. J Am Chem Soc (2010) 0.75